Cytokine Levels in Patients With Persistent Diabetic Macular Edema Treated With Triamcinolone Acetonide: an Interventional Prospective Study
Phase of Trial: Phase II
Latest Information Update: 20 Sep 2019
Price : $35 *
At a glance
- Drugs Triamcinolone (Primary)
- Indications Diabetic macular oedema
- Focus Biomarker; Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 10 Oct 2017 Status changed from recruiting to completed.
- 01 Dec 2015 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.